Detalhe da pesquisa
1.
Differential and organ-specific functions of organic solute transporter α and ß in experimental cholestasis.
JHEP Rep
; 4(5): 100463, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35462858
2.
Secondary (iso)BAs cooperate with endogenous ligands to activate FXR under physiological and pathological conditions.
Biochim Biophys Acta Mol Basis Dis
; 1867(8): 166153, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33895309
3.
Identification of FDA-approved drugs targeting the Farnesoid X Receptor.
Sci Rep
; 9(1): 2193, 2019 02 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30778102
4.
Intestinal Farnesoid X Receptor Activation by Pharmacologic Inhibition of the Organic Solute Transporter α-ß.
Cell Mol Gastroenterol Hepatol
; 5(3): 223-237, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29675448
5.
Designing modulators of 5-hydroxytryptamine signaling to treat abuse disorders.
Expert Opin Drug Discov
; 9(11): 1293-306, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25217125
6.
Knockdown of monocarboxylate transporter 8 (mct8) disturbs brain development and locomotion in zebrafish.
Endocrinology
; 155(6): 2320-30, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24693966